Executive Director, Chemical Biology/Drug Design
Recursion · Salt Lake City, Utah · Remote Opportunity - United States
CHECKED 39M AGO
Bio & Science AIremoteexecutive
At a glance
Highlights
- Lead chemical biology strategy bridging multiomic discovery to target ID.
- Expand platform into degraders, molecular glues and emerging modalities.
- Shape AI/ML-driven design platform for chemical probe decisions.
Ideal candidate
A strategic chemical biology leader with a decade of industry impact who thrives mentoring teams and bridging AI-driven discovery to first-in-class modalities.
Requirements
- PhD in chemical biology, chemistry, or related field with 10+ years of relevant industry experience and demonstrated people leadership
- Deep, hands-on track record in chemical probe design including selective inhibitors, molecular glue degraders/PROTACs and covalent or activity-based/photoaffinity chemistry
- Proven ability to deconvolute phenotypic hits to mechanism via chemoproteomics or equivalent target ID methods
- Track record building and scaling a chemical biology function
Lab profile
About Recursion
AI-native biotech industrializing drug discovery with automation and data to advance oncology and rare disease medicines.
What they build
- Recursion OS drug discovery platform
- Oncology clinical pipeline
- Rare disease clinical pipeline
Known for
- AI-native end-to-end drug discovery
- Computational biology for early discovery
- Clinical development in oncology and rare disease
Key facts
- Founded 2013
- Headquartered in Salt Lake City, Utah
- Public company (Nasdaq: RXRX)